{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T18:31:55Z","timestamp":1792693915682,"version":"4.5.0"},"reference-count":127,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.ijantimicag.2019.09.011","type":"journal-article","created":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T11:21:10Z","timestamp":1568892070000},"page":"105807","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":169,"title":["Azole resistance mechanisms in Aspergillus: update and recent advances"],"prefix":"10.1016","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9238-5849","authenticated-orcid":false,"given":"Alba","family":"P\u00e9rez-Cantero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loida","family":"L\u00f3pez-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Guarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0765-6403","authenticated-orcid":false,"given":"Javier","family":"Capilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0001","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.simyco.2014.07.004","article-title":"Phylogeny, identification and nomenclature of the genus Aspergillus","volume":"78","author":"Samson","year":"2014","journal-title":"Stud Mycol"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0002","doi-asserted-by":"crossref","first-page":"773","DOI":"10.3389\/fmicb.2014.00773","article-title":"Taxonomy, chemodiversity, and chemoconsistency of Aspergillus, Penicillium, and Talaromyces species","volume":"5","author":"Frisvad","year":"2015","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0003","article-title":"Allergic Aspergillus rhinosinusitis","volume":"2","author":"Chakrabarti","year":"2016","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0004","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.jaip.2014.08.007","article-title":"Allergic bronchopulmonary aspergillosis","volume":"2","author":"Greenberger","year":"2014","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0005","doi-asserted-by":"crossref","first-page":"e3747","DOI":"10.1097\/MD.0000000000003747","article-title":"Factors affecting patient outcome in primary cutaneous aspergillosis","volume":"95","author":"Tatara","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0006","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/thoraxjnl-2014-206291","article-title":"The clinical spectrum of pulmonary aspergillosis","volume":"70","author":"Kosmidis","year":"2015","journal-title":"Thorax"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0007","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2015-210381","article-title":"An unusual case of invasive aspergillosis in an immunocompetent individual","volume":"2015","author":"Mohammed","year":"2015","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0008","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s11046-015-9903-4","article-title":"Disseminated aspergillosis in the immunocompetent host: a case report and literature review","volume":"180","author":"Cheon","year":"2015","journal-title":"Mycopathologia"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0009","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.medmal.2013.11.006","article-title":"Diagnosis of invasive pulmonary aspergillosis: updates and recommendations","volume":"44","author":"Desoubeaux","year":"2014","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0010","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0011","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1439-0507.2009.01691.x","article-title":"The changing face of epidemiology of invasive fungal disease in Europe","volume":"52","author":"Lass-Fl\u00f6rl","year":"2009","journal-title":"Mycoses"},{"issue":"Suppl 1","key":"10.1016\/j.ijantimicag.2019.09.011_bib0012","doi-asserted-by":"crossref","first-page":"i5","DOI":"10.1093\/jac\/dkx028","article-title":"Changes in the epidemiological landscape of invasive mould infections and disease","volume":"72","author":"Lass-Fl\u00f6rl","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0013","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13054-014-0722-7","article-title":"Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomes","volume":"19","author":"Taccone","year":"2015","journal-title":"Crit Care"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0014","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s40265-017-0714-4","article-title":"Triazole resistance in Aspergillus species: an emerging problem","volume":"77","author":"Garcia-Rubio","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0015","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/myc.12469","article-title":"Epidemiology and molecular mechanisms of antifungal resistance in Candida and Aspergillus","volume":"59","author":"Gon\u00e7alves","year":"2016","journal-title":"Mycoses"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0016","doi-asserted-by":"crossref","first-page":"165rv13","DOI":"10.1126\/scitranslmed.3004404","article-title":"Hidden killers: human fungal infections","volume":"4","author":"Brown","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0017","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s12154-014-0121-1","article-title":"Resistance to antifungals that target CYP51","volume":"7","author":"Parker","year":"2014","journal-title":"J Chem Biol"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0018","doi-asserted-by":"crossref","first-page":"23916","DOI":"10.1074\/jbc.M115.677310","article-title":"Structure\u2013functional characterization of cytochrome P450 sterol 14\u03b1-demethylase (CYP51B) from Aspergillus fumigatus and molecular basis for the development of antifungal drugs","volume":"290","author":"Hargrove","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0019","doi-asserted-by":"crossref","first-page":"6441","DOI":"10.1021\/bi300744z","article-title":"1,2,3-Triazole\u2013heme interactions in cytochrome P450: functionally competent triazole\u2013water\u2013heme complexes","volume":"51","author":"Conner","year":"2012","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0020","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1128\/JCM.39.7.2431-2438.2001","article-title":"Identification of two different 14-\u03b1 sterol demethylase-related genes (cyp51A and cyp51B) in Aspergillus fumigatus and other Aspergillus species","volume":"39","author":"Mellado","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0021","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1128\/AAC.40.2.279","article-title":"Antifungal agents: chemotherapeutic targets and immunologic strategies","volume":"40","author":"Georgopapadakou","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0022","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1128\/AAC.00233-15","article-title":"Nationwide surveillance of azole resistance in Aspergillus diseases","volume":"59","author":"Vermeulen","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0023","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1128\/AEM.00231-09","article-title":"Possible environmental origin of resistance of Aspergillus fumigatus to medical triazoles","volume":"75","author":"Snelders","year":"2009","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0024","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/1471-2180-14-155","article-title":"Development of cross-resistance by Aspergillus fumigatus to clinical azoles following exposure to prochloraz, an agricultural azole","volume":"14","author":"Faria-Ramos","year":"2014","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0025","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.3389\/fmicb.2016.01382","article-title":"Epidemiological and genomic landscape of azole resistance mechanisms in Aspergillus fungi","volume":"7","author":"Hagiwara","year":"2016","journal-title":"Front Microbiol"},{"issue":"Suppl 3","key":"10.1016\/j.ijantimicag.2019.09.011_bib0026","doi-asserted-by":"crossref","first-page":"S436","DOI":"10.1093\/infdis\/jix210","article-title":"Azole-resistant aspergillosis: epidemiology, molecular mechanisms, and treatment","volume":"216","author":"Chowdhary","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0027","doi-asserted-by":"crossref","first-page":"E248","DOI":"10.1111\/j.1469-0691.2012.03890.x","article-title":"Hope WW; European Committee on Antimicrobial Susceptibility Testing Subcommittee on Antifungal Susceptibility Testing (EUCAST-AFST). EUCAST technical note on Aspergillus and amphotericin B, itraconazole, and posaconazole","volume":"18","author":"Arendrup","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0028","doi-asserted-by":"crossref","first-page":"E278","DOI":"10.1111\/1469-0691.12148","article-title":"Arendrup MC; European Committee on Antimicrobial Susceptibility Testing\u2013Subcommittee on Antifungal Susceptibility Testing (EUCAST-AFST). EUCAST technical note on voriconazole and Aspergillus spp","volume":"19","author":"Hope","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0029","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.cmi.2016.01.017","volume":"22","author":"Arendrup","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0030","series-title":"Reference method for broth dilution antifungal susceptibility testing of filamentous fungi","year":"2017"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0031","series-title":"Antifungal agents. Breakpoint tables for interpretation of MICs. Version 9.0","year":"2018"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0032","article-title":"Susceptibility testing of fungi to antifungal drugs","volume":"4","author":"Sanguinetti","year":"2018","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0033","series-title":"Epidemiological cutoff values for antifungal susceptibility testing","year":"2018"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0034","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.riam.2016.04.001","article-title":"The role of epidemiological cutoff values (ECVs\/ECOFFs) in antifungal susceptibility testing and interpretation for uncommon yeasts and moulds","volume":"33","author":"Espinel-Ingroff","year":"2016","journal-title":"Rev Iberoam Micol"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0035","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1038\/s41467-018-05497-7","article-title":"Azole-induced cell wall carbohydrate patches kill Aspergillus fumigatus","volume":"9","author":"Gei\u00dfel","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0036","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1128\/AAC.02244-13","article-title":"Transcription factor CCG-8 as a new regulator in the adaptation to antifungal azole stress","volume":"58","author":"Sun","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0037","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s12275-015-5014-7","article-title":"The molecular mechanism of azole resistance in Aspergillus fumigatus: from bedside to bench and back","volume":"53","author":"Wei","year":"2015","journal-title":"J Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0038","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1093\/molbev\/msu134","article-title":"Paralog re-emergence: a novel, historically contingent mechanism in the evolution of antimicrobial resistance","volume":"31","author":"Hawkins","year":"2014","journal-title":"Mol Biol Evol"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0039","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1128\/CMR.00095-16","article-title":"Molecular tools for the detection and deduction of azole antifungal drug resistance phenotypes in Aspergillus species","volume":"30","author":"Dudakova","year":"2017","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0040","doi-asserted-by":"crossref","first-page":"4920","DOI":"10.1128\/AAC.00349-10","article-title":"Complementation of a Saccharomyces cerevisiae ERG11\/CYP51 (sterol 14\u03b1-demethylase) doxycycline-regulated mutant and screening of the azole sensitivity of Aspergillus fumigatus isoenzymes CYP51A and CYP51B","volume":"54","author":"Martel","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0041","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/myc.12417","article-title":"cyp51A gene silencing using RNA interference in azole-resistant Aspergillus fumigatus","volume":"58","author":"Mousavi","year":"2015","journal-title":"Mycoses"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0042","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1371\/journal.ppat.0030024","article-title":"Essential gene identification and drug target prioritization in Aspergillus fumigatus","volume":"3","author":"Hu","year":"2007","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0043","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1128\/AAC.49.6.2536-2538.2005","article-title":"Targeted gene disruption of the 14-\u03b1 sterol demethylase (cyp51A) in Aspergillus fumigatus and its role in azole drug susceptibility","volume":"49","author":"Mellado","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0044","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01022-18","article-title":"Magnitude of voriconazole resistance in clinical and environmental isolates of Aspergillus flavus and investigation into the role of multidrug efflux pumps","volume":"62","author":"Paul","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0045","doi-asserted-by":"crossref","first-page":"7771","DOI":"10.1128\/AAC.01806-15","article-title":"In vitro biochemical study of CYP51-mediated azole resistance in Aspergillus fumigatus","volume":"59","author":"Warrilow","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0046","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.bbagen.2006.07.018","article-title":"Sterol 14a-demethylase cytochrome P450 (CYP51), a P450 in all biological kingdoms","volume":"1770","author":"Lepesheva","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0047","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/mmy\/myv102","article-title":"cyp51A-based mechanism of azole resistance in Aspergillus fumigatus\u00a0: illustration by a new 3D structural model of Aspergillus fumigatus CYP51A protein","volume":"54","author":"Liu","year":"2016","journal-title":"Med Mycol"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0048","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.1128\/AAC.00185-11","article-title":"Azole resistance in Aspergillus fumigatus isolates from the ARTEMIS global surveillance study is primarily due to the TR\/L98H mutation in the cyp51A gene","volume":"55","author":"Lockhart","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0049","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00241-18","article-title":"Insight into the significance of Aspergillus fumigatus cyp51A polymorphisms","volume":"62","author":"Garcia-Rubio","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0050","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1128\/AAC.47.2.577-581.2003","article-title":"Mutations in Aspergillus fumigatus resulting in reduced susceptibility to posaconazole appear to be restricted to a single amino acid in the cytochrome P450 14\u03b1-demethylase","volume":"47","author":"Mann","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0051","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1128\/AAC.47.5.1719-1726.2003","article-title":"Multiple resistance mechanisms among Aspergillus fumigatus mutants with high-level resistance to itraconazole","volume":"47","author":"Nascimento","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0052","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.diagmicrobio.2012.06.030","article-title":"In vitro\u2013in vivo correlation of voriconazole resistance due to G448S mutation (cyp51A gene) in Aspergillus fumigatus","volume":"74","author":"Krishnan Natesan","year":"2012","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0053","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1128\/AAC.00167-13","article-title":"cyp51A-based mechanisms of Aspergillus fumigatus azole drug resistance present in clinical samples from Germany","volume":"57","author":"Bader","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0054","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/AAC.05088-11","article-title":"Rapid induction of multiple resistance mechanisms in Aspergillus fumigatus during azole therapy: a case study and review of the literature","volume":"56","author":"Camps","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0055","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/myc.12324","article-title":"Multi-triazole-resistant Aspergillus fumigatus infections in Australia","volume":"58","author":"Kidd","year":"2015","journal-title":"Mycoses"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0056","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/jac\/dkq450","article-title":"Low prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological malignancies","volume":"66","author":"Alanio","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0057","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1093\/jac\/dku316","article-title":"Aspergillus fumigatus harbouring the sole Y121F mutation shows decreased susceptibility to voriconazole but maintained susceptibility to itraconazole and posaconazole","volume":"69","author":"Lescar","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0058","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1128\/JCM.02478-15","article-title":"First detection of TR34 L98H and TR46 Y121F T289A Cyp51 mutations in Aspergillus fumigatus isolates in the United States","volume":"54","author":"Wiederhold","year":"2016","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0059","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1128\/AAC.48.7.2747-2750.2004","article-title":"Substitutions at methionine 220 in the 14\u03b1-sterol demethylase (Cyp51A) of Aspergillus fumigatus are responsible for resistance in vitro to azole antifungal drugs","volume":"48","author":"Mellado","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0060","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3201\/eid1507.090043","article-title":"Frequency and evolution of azole resistance in Aspergillus fumigatus associated with treatment failure","volume":"15","author":"Howard","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0061","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/13693780902717018","article-title":"Acquired resistance to voriconazole and itraconazole in a patient with pulmonary aspergilloma","volume":"48","author":"Bellete","year":"2010","journal-title":"Med Mycol"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0062","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1093\/jac\/dkq279","article-title":"Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009","volume":"65","author":"Bueid","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0063","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1128\/AAC.01599-09","article-title":"Azole resistance profile of amino acid changes in Aspergillus fumigatus CYP51A based on protein homology modeling","volume":"54","author":"Snelders","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0064","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.1128\/AAC.00517-11","article-title":"Interrogation of related clinical pan-azole-resistant Aspergillus fumigatus strains: G138C, Y431C, and G434C single nucleotide polymorphisms in cyp51A, upregulation of cyp51A, and integration and activation of transposon Atf1 in the cyp51A promoter","volume":"55","author":"Albarrag","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0065","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ijantimicag.2008.06.018","article-title":"Molecular characterisation of cyp51A and cyp51B genes coding for P450 14\u03b1-lanosterol demethylases A (CYP51Ap) and B (CYP51Bp) from voriconazole-resistant laboratory isolates of Aspergillus flavus","volume":"32","author":"Krishnan-Natesan","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0066","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/cid\/cir179","article-title":"High-frequency triazole resistance found in nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease","volume":"52","author":"Denning","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0067","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1093\/jac\/dkt075","article-title":"The cdr1B efflux transporter is associated with non-cyp51a-mediated itraconazole resistance in Aspergillus fumigatus","volume":"68","author":"Fraczek","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0068","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1128\/AAC.05477-11","article-title":"The T788G mutation in the cyp51C gene confers voriconazole resistance in Aspergillus flavus causing aspergillosis","volume":"56","author":"Liu","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0069","doi-asserted-by":"crossref","first-page":"6615","DOI":"10.1128\/AAC.00637-15","article-title":"A novel Y319H substitution in CYP51C associated with azole resistance in Aspergillus flavus","volume":"59","author":"Paul","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0070","article-title":"Investigation of multiple resistance mechanisms in voriconazole-resistant Aspergillus flavus clinical isolates from a chest hospital surveillance in Delhi","volume":"62","author":"Sharma","year":"2018","journal-title":"India. Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0071","doi-asserted-by":"crossref","first-page":"4802","DOI":"10.1128\/AAC.00304-11","article-title":"Cryptic species and azole resistance in the Aspergillus niger complex","volume":"55","author":"Howard","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0072","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1128\/JCM.01075-16","article-title":"Species distribution and in vitro azole susceptibility of Aspergillus section Nigri isolates from clinical and environmental settings","volume":"54","author":"Iatta","year":"2016","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0073","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02583-16","article-title":"Drug sensitivity and resistance mechanism in Aspergillus section Nigri strains from Japan","volume":"61","author":"Hashimoto","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0074","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/infdis\/jis442","article-title":"In vivo emergence of Aspergillus terreus with reduced azole susceptibility and a Cyp51a M217I alteration","volume":"206","author":"Arendrup","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0075","doi-asserted-by":"crossref","first-page":"516","DOI":"10.3389\/fmicb.2018.00516","article-title":"Azole-resistance in Aspergillus terreus and related species: an emerging problem or a rare phenomenon?","volume":"9","author":"Zoran","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0076","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/jac\/48.1.75","article-title":"Resistance to itraconazole in Aspergillus nidulans and Aspergillus fumigatus is conferred by extra copies of the A. nidulans P-450 14\u03b1-demethylase gene, pdmA","volume":"48","author":"Osherov","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0077","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/jac\/dks451","article-title":"High-level expression of cyp51B in azole-resistant clinical Aspergillus fumigatus isolates","volume":"68","author":"Buied","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0078","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00543-19","article-title":"New insights into the Cyp51 contribution to azole resistance in Aspergillus section Nigri","volume":"63","author":"P\u00e9rez-Cantero","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0079","doi-asserted-by":"crossref","first-page":"e26990","DOI":"10.5812\/jjm.26990","article-title":"Evaluation of mRNA expression levels of cyp51A and mdr1, candidate genes for voriconazole resistance in Aspergillus flavus","volume":"8","author":"Fattahi","year":"2015","journal-title":"Jundishapur J Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0080","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1128\/AAC.01092-06","article-title":"A new Aspergillus fumigatus resistance mechanism conferring in vitro cross-resistance to azole antifungals involves a combination of cyp51A alterations","volume":"51","author":"Mellado","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0081","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.fgb.2011.08.002","article-title":"The structure\u2013function relationship of the Aspergillus fumigatus cyp51A L98H conversion by site-directed mutagenesis: the mechanism of L98H azole resistance","volume":"48","author":"Snelders","year":"2011","journal-title":"Fungal Genet Biol"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0082","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.fgb.2015.06.001","article-title":"Genotype\u2013phenotype complexity of the TR46\/Y121F\/T289A cyp51A azole resistance mechanism in Aspergillus fumigatus","volume":"82","author":"Snelders","year":"2015","journal-title":"Fungal Genet Biol"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0083","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/13693780802545600","article-title":"Multiple-azole-resistant Aspergillus fumigatus osteomyelitis in a patient with chronic granulomatous disease successfully treated with long-term oral posaconazole and surgery","volume":"47","author":"Hodiamont","year":"2009","journal-title":"Med Mycol"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0084","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1128\/AAC.00156-08","article-title":"Epidemiological cutoffs and cross-resistance to azole drugs in Aspergillus fumigatus","volume":"52","author":"Rodriguez-Tudela","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0085","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/cid\/cit320","article-title":"Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles","volume":"57","author":"van der Linden","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0086","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.3389\/fmicb.2018.01626","article-title":"Comparison of two highly discriminatory typing methods to analyze Aspergillus fumigatus azole resistance","volume":"9","author":"Garcia-Rubio","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0087","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3389\/fmicb.2017.00092","article-title":"Regulation of sterol biosynthesis in the human fungal pathogen Aspergillus fumigatus: opportunities for therapeutic development","volume":"8","author":"Dhingra","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0088","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1128\/AAC.05027-11","article-title":"SREBP-dependent triazole susceptibility in Aspergillus fumigatus is mediated through direct transcriptional regulation of erg11A (cyp51A)","volume":"56","author":"Blosser","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0089","doi-asserted-by":"crossref","first-page":"38833","DOI":"10.1038\/srep38833","article-title":"Sensitisation of an azole-resistant Aspergillus fumigatus strain containing the Cyp51A-related mutation by deleting the SrbA gene","volume":"6","author":"Hagiwara","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0090","doi-asserted-by":"crossref","first-page":"e50034","DOI":"10.1371\/journal.pone.0050034","article-title":"Discovery of a HapE mutation that causes azole resistance in Aspergillus fumigatus through whole genome sequencing and sexual crossing","volume":"7","author":"Camps","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0091","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02563-18","article-title":"AtrR is an essential determinant of azole resistance in Aspergillus fumigatus","volume":"10","author":"Paul","year":"2019","journal-title":"MBio"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0092","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006096","article-title":"A novel Zn2-Cys6 transcription factor AtrR plays a key role in an azole resistance mechanism of Aspergillus fumigatus by co-regulating cyp51A and cdr1B expressions","volume":"13","author":"Hagiwara","year":"2017","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0093","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1039\/C7MT00110J","article-title":"The cytochrome b5 CybE is regulated by iron availability and is crucial for azole resistance in A. fumigatus","volume":"9","author":"Misslinger","year":"2017","journal-title":"Metallomics"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0094","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1128\/AAC.01189-10","article-title":"Azole resistance of Aspergillus fumigatus biofilms is partly associated with efflux pump activity","volume":"55","author":"Rajendran","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000486","article-title":"Efflux in fungi: la pi\u00e8ce de r\u00e9sistance","volume":"5","author":"Coleman","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0096","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s40588-015-0015-1","article-title":"Update on antifungal drug resistance","volume":"2","author":"Perlin","year":"2015","journal-title":"Curr Clin Microbiol Rep"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0097","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1146\/annurev.micro.61.080706.093329","article-title":"Ins and outs of major facilitator superfamily antiporters","volume":"62","author":"Law","year":"2008","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0098","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/mmy\/myw005","article-title":"Identification of Aspergillus fumigatus multidrug transporter genes and their potential involvement in antifungal resistance","volume":"54","author":"Meneau","year":"2016","journal-title":"Med Mycol"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0099","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2174\/138945006776359403","article-title":"Fungal ATP-binding cassette (ABC) transporters in drug resistance & detoxification","volume":"7","author":"Sipos","year":"2006","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0100","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1128\/EC.00171-13","article-title":"Contributions of Aspergillus fumigatus ATP-binding cassette transporter proteins to drug resistance and virulence","volume":"12","author":"Paul","year":"2013","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0101","doi-asserted-by":"crossref","first-page":"e02748","DOI":"10.1128\/AAC.02748-16","article-title":"Contributions of both ATP-binding cassette transporter and Cyp51A proteins are essential for azole resistance in Aspergillus fumigatus","volume":"61","author":"Paul","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0102","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00294-006-0073-2","article-title":"Transcriptome analysis of Aspergillus fumigatus exposed to voriconazole","volume":"50","author":"da Silva Ferreira","year":"2006","journal-title":"Curr Genet"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0103","doi-asserted-by":"crossref","first-page":"4405","DOI":"10.1128\/AAC.48.11.4405-4413.2004","article-title":"In vitro evolution of itraconazole resistance in Aspergillus fumigatus involves multiple mechanisms of resistance","volume":"48","author":"da Silva Ferreira","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0104","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.diagmicrobio.2013.04.022","article-title":"Differential expression of ATP-binding cassette and\/or major facilitator superfamily class efflux pumps contributes to voriconazole resistance in Aspergillus flavus","volume":"76","author":"Natesan","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0105","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1087-1845(02)00016-6","article-title":"Increased expression of a novel Aspergillus fumigatus ABC transporter gene, atrF, in the presence of itraconazole in an itraconazole resistant clinical isolate","volume":"36","author":"Slaven","year":"2002","journal-title":"Fungal Genet Biol"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0106","first-page":"439","article-title":"Ergosterol biosynthesis in Aspergillus fumigatus: its relevance as an antifungal target and role in antifungal drug resistance","volume":"3","author":"Alcazar-Fuoli","year":"2012","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0107","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00437-19","article-title":"Mutations in hmg1, challenging the paradigm of clinical triazole resistance in Aspergillus fumigatus","volume":"10","author":"Rybak","year":"2019","journal-title":"MBio"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0108","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.3201\/eid2410.180730","article-title":"Non- cyp51A azole-resistant Aspergillus fumigatus isolates with mutation in HMG-CoA reductase","volume":"24","author":"Hagiwara","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0109","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00978-17","article-title":"Induction of mitochondrial reactive oxygen species production by itraconazole, terbinafine, and amphotericin B as a mode of action against Aspergillus fumigatus","volume":"61","author":"Shekhova","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158724","article-title":"Mitochondrial complex I is a global regulator of secondary metabolism, virulence and azole sensitivity in fungi","volume":"11","author":"Bromley","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0111","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s11046-010-9309-2","article-title":"Truncated Afyap1 attenuates antifungal susceptibility of Aspergillus fumigatus to voriconazole and confers adaptation of the fungus to oxidative stress","volume":"170","author":"Qiao","year":"2010","journal-title":"Mycopathologia"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0112","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1128\/EC.00267-07","article-title":"The Aspergillus fumigatus transcriptional regulator AfYap1 represents the major regulator for defense against reactive oxygen intermediates but is dispensable for pathogenicity in an intranasal mouse infection model","volume":"6","author":"Lessing","year":"2007","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0113","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01216-18","article-title":"Contributions of yap1 mutation and subsequent atrF upregulation to voriconazole resistance in Aspergillus flavus","volume":"62","author":"Ukai","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0114","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000471","article-title":"Hsp90 orchestrates stress response signaling governing fungal drug resistance","volume":"5","author":"Cowen","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0115","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1128\/AAC.02286-13","article-title":"Identification of a key lysine residue in heat shock protein 90 required for azole and echinocandin resistance in Aspergillus fumigatus","volume":"58","author":"Lamoth","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0116","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.1007\/s00253-016-8072-9","article-title":"Damage resistance protein (Dap) contributes to azole resistance in a sterol-regulatory-element-binding protein SrbA-dependent way","volume":"101","author":"Song","year":"2017","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0117","doi-asserted-by":"crossref","first-page":"e01919","DOI":"10.1128\/mBio.01919-15","article-title":"The Aspergillus fumigatus damage resistance protein family coordinately regulates ergosterol biosynthesis and azole susceptibility","volume":"7","author":"Song","year":"2016","journal-title":"MBio"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0118","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1080\/21505594.2016.1201250","article-title":"Calcineurin in fungal virulence and drug resistance: prospects for harnessing targeted inhibition of calcineurin for an antifungal therapeutic approach","volume":"8","author":"Juvvadi","year":"2017","journal-title":"Virulence"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0119","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.fgb.2014.12.005","article-title":"Calcium signaling mediates antifungal activity of triazole drugs in the Aspergilli","volume":"81","author":"Liu","year":"2015","journal-title":"Fungal Genet Biol"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0120","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ijmm.2010.03.001","article-title":"AfMkk2 is required for cell wall integrity signaling, adhesion, and full virulence of the human pathogen Aspergillus fumigatus","volume":"300","author":"Dirr","year":"2010","journal-title":"Int J Med Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0121","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1111\/mmi.12626","article-title":"Endoplasmic reticulum localized PerA is required for cell wall integrity, azole drug resistance, and virulence in Aspergillus fumigatus","volume":"92","author":"Chung","year":"2014","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0122","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4155\/fmc.13.189","article-title":"Reactive oxygen species-inducing antifungal agents and their activity against fungal biofilms","volume":"6","author":"Delattin","year":"2014","journal-title":"Future Med Chem"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0123","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002585","article-title":"Fungal biofilms","volume":"8","author":"Fanning","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0124","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/528521","article-title":"Fungal biofilm resistance","volume":"2012","author":"Ramage","year":"2012","journal-title":"Int J Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0125","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2217\/fmb.14.27","article-title":"Exploring azole antifungal drug resistance in Aspergillus fumigatus with special reference to resistance mechanisms","volume":"9","author":"Chowdhary","year":"2014","journal-title":"Future Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0126","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1128\/AAC.49.2.518-524.2005","article-title":"Cholesterol import by Aspergillus fumigatus and its influence on antifungal potency of sterol biosynthesis inhibitors","volume":"49","author":"Xiong","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.09.011_bib0127","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007478","article-title":"Finding the needle in a haystack: mapping antifungal drug resistance in fungal pathogen by genomic approaches","volume":"15","author":"Sanglard","year":"2019","journal-title":"PLoS Pathog"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857919302547?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857919302547?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:35:06Z","timestamp":1760376906000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857919302547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":127,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0924857919302547"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.09.011","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Azole resistance mechanisms in Aspergillus: update and recent advances","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105807"}}